a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PIPPX | 11.85 | 0.21 | +1.80% |
Principal MidCap Growth R4 | |||
UBVLX | 92.61 | 1.34 | +1.47% |
Undiscovered Managers Behavioral Val L | |||
UNWPX | 1.53 | 0.01 | +0.66% |
US Global Investors World Prec Mnral | |||
TCSHX | 14.53 | 0.06 | +0.41% |
Transamerica Multi-Asset Income C | |||
SIDVX | 10.19 | 0.01 | +0.10% |
Hartford Schroders Intl Multi-Cp Val A |
A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To PLRX | 1D Price Change % | ||
---|---|---|---|---|
PLRX | 100% | -0.47% | ||
NTLA - PLRX | 51% Loosely correlated | -7.15% | ||
RCKT - PLRX | 51% Loosely correlated | -0.91% | ||
BEAM - PLRX | 50% Loosely correlated | -3.16% | ||
ABSI - PLRX | 49% Loosely correlated | -1.47% | ||
PRME - PLRX | 48% Loosely correlated | -5.68% | ||
More |